Portolan Capital Management, LLC Harrow Health, Inc. Transaction History

Portolan Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$14.03 - $22.08 $10 Million - $15.7 Million	-713,035 Reduced 64.88%	385,964 $5.55 Million
Q2 2023 Aug 14, 2023	BUY	$17.37 - $28.08 $452,141 - $730,922	26,030 Added 2.43%	1,098,999 $20.9 Million
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $1.39 Million - $2.16 Million	100,457 Added 10.33%	1,072,969 $22.7 Million
Q4 2022 Feb 13, 2023	BUY	$10.28 - $14.78 $10 Million - $14.4 Million	972,512 New	972,512 $14.4 Million

178

21.3M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $926M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Portolan Capital Management, LLC with notifications on news.